M
Margo Minissian
Researcher at Cedars-Sinai Medical Center
Publications - 61
Citations - 4420
Margo Minissian is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Coronary artery disease & Medicine. The author has an hindex of 16, co-authored 50 publications receiving 3658 citations. Previous affiliations of Margo Minissian include University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update A Guideline From the American Heart Association and American College of Cardiology Foundation
Sidney C. Smith,Emelia J. Benjamin,Robert O. Bonow,Lynne T. Braun,Mark A. Creager,Barry A. Franklin,Raymond J. Gibbons,Scott M. Grundy,Loren F. Hiratzka,Daniel W. Jones,Donald M. Lloyd-Jones,Margo Minissian,Lori Mosca,Eric D. Peterson,Ralph L. Sacco,John A. Spertus,James H. Stein,Kathryn A. Taubert +17 more
TL;DR: The development of the present guideline involved a process of partial adaptation of other guideline statements and reports and supplemental literature searches, which confirmed that in patients with atherosclerotic vascular disease, comprehensive risk factor management reduces risk as assessed by a variety of outcomes.
Journal ArticleDOI
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
Sidney C. Smith,Emelia J. Benjamin,Robert O. Bonow,Lynne T. Braun,Mark A. Creager,Barry A. Franklin,Raymond J. Gibbons,Scott M. Grundy,Loren F. Hiratzka,Daniel W. Jones,Donald M. Lloyd-Jones,Margo Minissian,Lori Mosca,Eric D. Peterson,Ralph L. Sacco,John A. Spertus,James H. Stein,Kathryn A. Taubert +17 more
TL;DR: In this article, the authors present the 2006 update of the American Heart Association (AHA)/American College of Cardiology Foundation (ACCF) guidelines on secondary prevention and provide evidence from clinical trials that further supports and broadens the merits of intensive risk-reduction therapies for secondary prevention.
Journal ArticleDOI
2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents
Donald M. Lloyd-Jones,Pamela B. Morris,Christie M. Ballantyne,Kim K. Birtcher,David D. Daly,Sondra M. DePalma,Margo Minissian,Carl E. Orringer,Sidney C. Smith +8 more
TL;DR: This work was supported by a grant from the National Institutes of Health (NIH) and a collection of donations made by the public and private sectors.
Journal ArticleDOI
2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways
Donald M. Lloyd-Jones,Pamela B. Morris,Christie M. Ballantyne,Kim K. Birtcher,David D. Daly,Sondra M. DePalma,Margo Minissian,Carl E. Orringer,Sidney C. Smith +8 more
TL;DR: A focused update on the role of non-statin therapies for low-density lipoprotein (LDL)-cholesterol lowering in the management of atherosclerotic cardiovascular disease (ASCVD) risk is provided, with down-graded recommendations regarding bile acid sequestrant use.
Journal ArticleDOI
Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease
Puja K. Mehta,Pavel Goykhman,Louise Thomson,Chrisandra Shufelt,Janet Wei,Yuching Yang,Edward Gill,Margo Minissian,Leslee J. Shaw,Piotr J. Slomka,Melissa Slivka,Daniel S. Berman,C. Noel Bairey Merz +12 more
TL;DR: In women with angina, evidence of ischemia, and no obstructive CAD, this pilot randomized, controlled trial revealed that ranolazine improves angina and myocardial ischemIA may also improve, particularly among women with low CFR.